CALT [NASD]
Calliditas Therapeutics AB (publ)
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand26.17M Perf Week29.57%
Market Cap492.01M Forward P/E4.88 EPS next Y3.85 Insider Trans- Shs Float15.83M Perf Month10.04%
Income- PEG- EPS next Q-1.02 Inst Own4.08% Short Float0.40% Perf Quarter-2.13%
Sales- P/S- EPS this Y16.20% Inst Trans- Short Ratio5.66 Perf Half Y0.51%
Book/sh- P/B- EPS next Y300.50% ROA- Target Price61.75 Perf Year-37.21%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range12.55 - 33.19 Perf YTD-24.07%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-43.36% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low49.80% ATR1.00
Employees66 Current Ratio- Sales Q/Q7695.00% Oper. Margin- RSI (14)64.67 Volatility5.49% 4.30%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.36 Prev Close19.45
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume11.32K Price18.80
Recom1.20 SMA2024.72% SMA509.38% SMA200-8.71% Volume15,704 Change-3.34%
Feb-26-21Initiated H.C. Wainwright Buy $52
Jul-01-20Initiated Citigroup Buy $36
Jun-30-20Initiated Jefferies Buy $44
May-19-22 03:21PM  
10:46AM  
08:41AM  
May-18-22 01:30AM  
May-17-22 05:18AM  
May-14-22 08:00AM  
May-10-22 02:43AM  
Apr-29-22 04:18AM  
Apr-27-22 12:13PM  
12:10PM  
Apr-14-22 03:30AM  
03:28AM  
Mar-24-22 07:11AM  
Mar-22-22 03:09PM  
08:02AM  
Mar-18-22 03:19AM  
03:18AM  
Mar-14-22 02:24AM  
Mar-13-22 08:00PM  
Feb-24-22 04:41AM  
01:37AM  
Feb-15-22 04:40AM  
04:39AM  
Jan-28-22 02:16AM  
Dec-16-21 09:26AM  
08:40AM  
07:52AM  
06:26AM  
Dec-15-21 05:05PM  
05:04PM  
Nov-18-21 01:21AM  
01:12AM  
Nov-03-21 04:42AM  
Nov-02-21 05:17AM  
Oct-07-21 06:32AM  
02:22AM  
Sep-16-21 08:55AM  
08:52AM  
Sep-15-21 07:38AM  
06:49AM  
Sep-14-21 05:27PM  
05:26PM  
Sep-12-21 04:04PM  
Aug-31-21 02:42AM  
02:40AM  
Aug-19-21 01:21AM  
Aug-12-21 06:47PM  
12:52PM  
Aug-10-21 08:48AM  
Aug-09-21 03:15AM  
Jul-21-21 06:56AM  
03:05AM  
Jul-15-21 03:02AM  
May-28-21 09:09AM  
09:06AM  
06:14AM  
May-27-21 12:48PM  
12:45PM  
May-18-21 06:45AM  
01:16AM  
01:11AM  
May-14-21 08:14AM  
08:12AM  
May-03-21 08:53AM  
08:51AM  
Apr-28-21 04:06AM  
04:05AM  
Apr-27-21 08:44AM  
08:43AM  
08:42AM  
Apr-26-21 06:32AM  
06:29AM  
Apr-23-21 02:57AM  
Mar-15-21 06:45AM  
03:04AM  
02:58AM  
Mar-08-21 02:57AM  
02:57AM  
02:53AM  
Mar-04-21 09:14AM  
09:12AM  
Feb-18-21 06:30AM  
01:12AM  
01:10AM  
Feb-04-21 08:05AM  
02:48AM  
02:46AM  
Jan-28-21 09:03AM  
09:01AM  
Jan-26-21 04:59PM  
04:56PM  
Jan-21-21 02:45AM  
Jan-20-21 07:32AM  
02:13AM  
Jan-18-21 02:13AM  
Jan-15-21 03:48AM  
03:44AM  
Dec-16-20 11:59AM  
11:56AM  
Dec-11-20 02:00PM  
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. The company's lead product candidate is Nefecon, a oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease IgA nephropathy. Calliditas Therapeutics AB (publ) was founded in 2004 and is headquartered in Stockholm, Sweden.